Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Equity Ratio (2016 - 2021)

Historic Equity Ratio for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to 0.86.

  • ENDRA Life Sciences' Equity Ratio rose 3810.16% to 0.86 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.86, marking a year-over-year increase of 3810.16%. This contributed to the annual value of 0.82 for FY2020, which is 2329.86% up from last year.
  • Per ENDRA Life Sciences' latest filing, its Equity Ratio stood at 0.86 for Q3 2021, which was up 3810.16% from 0.87 recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Equity Ratio registered a high of 0.98 during Q2 2017, and its lowest value of 2.53 during Q1 2017.
  • For the 5-year period, ENDRA Life Sciences' Equity Ratio averaged around 0.51, with its median value being 0.77 (2018).
  • As far as peak fluctuations go, ENDRA Life Sciences' Equity Ratio crashed by 13696.31% in 2018, and later soared by 20953.48% in 2019.
  • Over the past 5 years, ENDRA Life Sciences' Equity Ratio (Quarter) stood at 0.86 in 2017, then increased by 0.42% to 0.87 in 2018, then decreased by 23.31% to 0.66 in 2019, then increased by 23.3% to 0.82 in 2020, then grew by 5.03% to 0.86 in 2021.
  • Its last three reported values are 0.86 in Q3 2021, 0.87 for Q2 2021, and 0.94 during Q1 2021.